The big question hanging over the International AIDS Conference this week is whether all 34 million people in the world with HIV can possibly get antiviral drug treatment.
New guidelines released at the Washington meeting call for everybody with HIV to be started on anti-retroviral drugs as soon as they test positive for the virus. New research shows that’s better for their long-term health, and it will help end the pandemic because people in treatment are less likely to infect others.
But it’s probably safe to say that all 22,000 people attending the biennial meeting in Washington, D.C., have been thinking and talking all week about just whether the goal is achievable, and who would pay for this enormous expansion in treatment.
Read this story now for free
To continue reading, sign up for our newsletter and get unlimited access to WABE.org
You can select your preferences for news and local content. We will never share your email address. Learn how your newsletter sign-up will support WABE and Public Media
